PhytoHealth Corporation

Taiwan Stock Exchange 4108.TW

PhytoHealth Corporation Price to Earnings Ratio (P/E) on January 14, 2025: -63.49

PhytoHealth Corporation Price to Earnings Ratio (P/E) is -63.49 on January 14, 2025, a 34.82% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

PhytoHealth Corporation 52-week high Price to Earnings Ratio (P/E) is -62.69 on December 23, 2024, which is 1.27% above the current Price to Earnings Ratio (P/E).
PhytoHealth Corporation 52-week low Price to Earnings Ratio (P/E) is -103.50 on February 26, 2024, which is -63.01% below the current Price to Earnings Ratio (P/E).
PhytoHealth Corporation average Price to Earnings Ratio (P/E) for the last 52 weeks is -81.46.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Taiwan Stock Exchange: 4108.TW

PhytoHealth Corporation

CEO	Ms. Yi-Li Lee
IPO Date	July 16, 2008
Location	Taiwan
Headquarters	No.167, Fu Hsing North Road
Employees	84
Sector	Health Care
Industries Pharmaceuticals

Description

PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and supplementary foods and other related products. Its products include PG2 Lyophilized injection for the treatment of cancer related fatigue; EnerCharge, which is used in enhancing physical strength, maintaining good spirits, and enhancing health maintenance activities; ReyeasCleanse health food capsules; and EnerCharge, an energy drink. The company also offers precision medical equipment and instrument; medical diagnosis software; and computer-aided diagnosis system authorization services. PhytoHealth Corporation was incorporated in 1998 and is based in Taipei, Taiwan.

Key trends

Past 5 years